The most common problems of antibody expression projects are inadequate antibody yield, lengthy completion time, often requiring many months, and cost overruns. To address these constraints ...

Sino Biological provides four major antibody development platforms and four major protein expression platforms, which enable engagement in early development projects of multispecific antibody ...

Cell lines commonly used for monoclonal antibody expression include Chinese hamster ovary (CHO) and human embryonic kidney 293 (HEK293) cells. But even if researchers have worked with these wild ...

Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA service, delivering precision solutions in cytokine assays, custom monoclonal antibodies, and ...

Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...

Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor ...

Novel CD37 antibody-drug conjugate shows promise in targeting the Achilles’ heel of acute myeloid leukemia cells.

Uliledlimab is an antibody designed to target CD73. The development pause will also allow I-Mab to allow data from an ongoing China-only randomised study conducted by its partner ...